Abstract
Comment and summary
The average daily dose of EACA was 9.0 g, a very large amount as compared to the usual human dose of 10 to 20 g per day. In vitro tests (not illustrated) demonstrated that EACA inhibited dog fibrinolysin and SK-activation of profibrinolysin at concentrations of 0.02–0.06%. In the treated dogs the “spontaneous”fibrinolytic activity of the plasma and its euglobulin fraction were significantly lessened. No changes in coagulation factor levels or in survival of fibrinogen I131 were noted.
Get full access to this article
View all access options for this article.